Upon exposure to VSV-GFP infection, circRIG-I-MS2 elicited similar antiviral effects of circRIG-I, which further confirmed the availability of circRIG-I-MS2 (Supplementary Fig. 12a). This evidence concerns the gene ADAM8 and infection.